4.41
-0.22(-4.75%)
Currency In USD
| Previous Close | 4.63 |
| Open | 4.58 |
| Day High | 4.81 |
| Day Low | 4.21 |
| 52-Week High | 5.92 |
| 52-Week Low | 0.52 |
| Volume | 1.08M |
| Average Volume | 1.48M |
| Market Cap | 176.71M |
| PE | -3.22 |
| EPS | -1.37 |
| Moving Average 50 Days | 3.36 |
| Moving Average 200 Days | 1.81 |
| Change | -0.22 |
If you invested $1000 in Neuronetics, Inc. (STIM) since IPO date, it would be worth $158.75 as of March 14, 2025 at a share price of $4.41. Whereas If you bought $1000 worth of Neuronetics, Inc. (STIM) shares 5 years ago, it would be worth $2,273.2 as of March 14, 2025 at a share price of $4.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
GlobeNewswire Inc.
Feb 21, 2025 1:30 PM GMT
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disord
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
GlobeNewswire Inc.
Feb 07, 2025 12:54 PM GMT
MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced that it has priced its previously announced underwritten public offering of its common stock, comprised of 8,000,000 shares of common s
Neuronetics Announces Launch of Underwritten Public Offering of Common Stock
GlobeNewswire Inc.
Feb 06, 2025 9:23 PM GMT
MALVERN, Pa., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, the Company expects to gran